KRAS and colorectal carcinoma: In CRC, compared to wild-type KRAS, KRAS-mutated patients exhibited a relationship with abundance of CD8+ T cells and prognosis, and the CD8+ T cells showed high sensitivity of T cell activation-induced cell death (AICD) [132].